Literature DB >> 3425152

Retrospective evaluation of gynecologic cytodiagnosis. II. Interlaboratory reproducibility as shown in rescreening large consecutive samples of reported cases.

A R Yobs1, A E Plott, M D Hicklin, S A Coleman, W W Johnston, P R Ashton, I F Rube, J C Watts, Z M Naib, R J Wood.   

Abstract

Two laboratories exchanged and rescreened a large sample of cases with cervicovaginal smears they had consecutively accessioned to examine the reproducibility of gynecologic cytodiagnosis under optimum conditions. At least a "working agreement" (diagnoses within +/- 1 category on a ten-category scale) was achieved in diagnoses of normal, benign reaction and squamous abnormality (from minimal dysplasia though invasive cancer) in 18,859 cases (96.8%), of endometrial abnormality in 21 cases (42%) and of "unsatisfactory" in 99 cases (20.7%). Larger differences occurred in greater than or equal to 30% of cases except in the categories of "normal" and "benign reaction," reaching a maximum of 82% for moderate dysplasia. Reexamining 382 cases decreased disagreement by category to the 20% to 65% range only in the five categories of dysplasia plus carcinoma in situ. Agreement was not predicated on the presence of endocervical cells or squamous metaplasia; the basis for "unsatisfactory" calls was not uniform. Comparison of the laboratories' diagnoses with referee diagnoses or, on 178 cases, with tissue diagnoses also demonstrated differences in diagnostic criteria.

Entities:  

Mesh:

Year:  1987        PMID: 3425152

Source DB:  PubMed          Journal:  Acta Cytol        ISSN: 0001-5547            Impact factor:   2.319


  3 in total

1.  Problems of follow-up for abnormal cervical smears: discussion paper.

Authors:  R Ellman
Journal:  J R Soc Med       Date:  1990-02       Impact factor: 5.344

2.  Optimization of cervical cancer screening.

Authors:  L Gustafsson; H O Adami
Journal:  Cancer Causes Control       Date:  1992-03       Impact factor: 2.506

3.  Scientific issues related to the cytology proficiency testing regulations.

Authors:  George Birdsong; Lydia Howell; Karen Atkison; R Marshall Austin; Marluce Bibbo; Thomas A Bonfiglio; Diane D Davey; Catherine Keebler; Dina Mody; Lynnette Savaloja; Jacalyn Papillo; Marianne Prey; Stephen Raab; Brenda L Schultz; Diane Solomon
Journal:  Cytojournal       Date:  2006-04-18       Impact factor: 2.091

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.